Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: A prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping

Acta Medica Okayama

Volumn 58, Issue 1, 2004, Pages 45-49

  Araki, Tohru ^a   Yokoyama, Teruhiko ^b   Kumon, Hiromi ^b  

^a Araki Urological Clinic   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Loxoprofen sodium; Nocturia; Non steroidal anti inflammatory drugs (NSAIDs)

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; LOXOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VASOPRESSIN DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUESTIONNAIRE; RANDOMIZATION; SIDE EFFECT; STOMACH DISEASE; THROAT DISEASE; TREATMENT OUTCOME; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; MALE; MIDDLE AGED; PHENYLPROPIONATES; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SLEEP; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 1642485727     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Resnick NM and Yalla SV: Geriatric incontinence and voiding dysfunction; in Campbell's Urology, Walsh PC, Retik AB, Vaughan ED and Wein AJ eds, 7th Ed, Saunders, Philadelphia (1998) pp 1044-1058.
2. Johnson TM, Jones K, Williford WO, Kutner MH, Issa MM and Lepor H: Changes in nocturia from medical treatment of benign prostatic hyperplasia: Secondary Analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol (2003) 170: 145-148.
3. Herbert RL, Jacobson HR, Fredin D and Breyer MD: Evidences that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol (1993) 265: 643-650.
4. Maggi CA: Prostanoids as local modulators of reflex micturition. Pharmacol Res (1992) 25: 13-20.
5. Al-Waili NS: Increased urinary nitrite excretion in primary enuresis: Effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretion. BJU Int (2002) 90: 294-301.
6. Weiss JP and Blaivas JG: Nocturia. J Urol (2000) 163: 5-12.
7. Al-Waili NS: Indomethacin suppositories: An alternative treatment for nocturnal frequency of micturition. IRCS Med Sci (1986) 14: 322-323.
8. Yokoyama O, Komatsu K, Ishiura Y, Akino H, Kodama K, Yotsuyanagi S, Moriyama N, Nagasaka Y, Ito Y and Namiki M: Overactive bladder-experimental aspects. Scand J Urol Nephrol Suppl (2002) 210: 59-64.
9. Wen SF: Nephrotoxicities of nonsteroidal anti-inflammatory drugs. J Formos Med Assoc (1997) 96: 157-171.
10. Abrams PH and Feneley RC: The actions of prostaglandins on the smooth muscle of the human urinary tract in vitro. Br J Urol (1976) 47: 909-915.
11. Andersson KE, Ek A and Persson CG: Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol Scand (1977) 100: 165-171.
12. Pfandner K: Nimesulide and antibiotics in the treatment of acute urinary tract infections. Arzneimittelforschung (1984) 34: 77-79.
13. Nakano E, Yoshioka T, Matsuda M, Sonoda T, Yano H, Ihara Y, Kuroda H, Kishimoto T, Sakurai T and Uchida K: Clinical effect of LM-001, prostaglandin synthetic inhibitor, on pain from urinary tract stone and vesical urgency after operation of the bladder or prostate. Acta Urol Jpn (1990) 36: 635-642 (in Japanese).
14. Cardozo LD, Stanton SL, Robbinson H and Hole D: Evaluation on flurbiprofen in detrusor instability. Br Med J (1980) 280: 281-282.
15. Cardozo LD and Stanton SL: A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol (1980) 123: 399-401.
16. Delaere KP, Debruyne FM and Moonen WA: The use of indomethacin in the treatment of idiopathic bladder instability. Urol Int (1980) 36: 124-127.
17. Palmer J: Report of a double-blind crossover study of flurbiprofen and placebo in detrusor instability. J Int Med Res (1983) 11:11-17.
18. Andersson KE: Treatment of overactive bladder: Other drug mechanisms. Urology (2000) 55: 51-57.
19. Andersson KE and Sjogren C: Aspects of the physiology and pharmacology of the bladder and urethra. Prog Neurobiol (1982) 19: 71-89.
20. Palea S, Toson G, Pietra C, Trist DG, Artibani W, Romano O and Corsi M: Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. Br J Pharmacol (1998) 124: 865-872.
21. Al-Waili NS: Diclofenac sodium in the treatment of primary nocturnal enuresis: Double-blind crossover study. Clin Exp Pharmacol Physiol (1986) 13: 139-142.
22. Al-Waili NS: Indomethacin suppository to treat primary nocturnal enuresis: Double-blind study. J Urol (1989) 142: 1290-1292.
23. Urade Y and Hayaishi O: Prostaglandin D2 and sleep regulation. Biochim Biophys Acta (1999) 1436: 606-615.
24. Yoshida Y, Matsumura H, Nakajima T, Mandai M, Urakami T, Kuroda K and Yoneda H: Prostaglandin E (EP) receptor subtypes and sleep: Promotion by EP4 and inhibition by EPI/EP2. Neuroreport (2000) 11: 2127-2131.
25. Wolfe MM, Lichtenstein DR and Singh G: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med (1999) 340: 1888-1899.
26. Griffin MR, Yared A and Ray WA: Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol (2000) 151: 488-496.